ganoderma lucidum spore

Botanicalexperimental

Clinical trial activity

7 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
5
Phase 3
2
Phase 4
0

Earliest trial started Jun 1, 2014 (NCT02238587)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2016

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ganoderma lucidum spore
  • ganoderma spore lipids
  • ganoderma spores
  • ganoderma tea

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04319874Phase 2Sep 15, 2020Zhejiang University
NCT04914143N/AJun 6, 2020Zhejiang University
NCT03594656Phase 3Jul 15, 2018Capital Medical University
NCT02785523Phase 3May 1, 2016Dalian Medical University
NCT02844114Phase 2Jan 1, 2016Dalian Medical University, The First Affiliated Hospital of Dalian Medical University
NCT02533635Phase 1/Phase 2 (Phase 2)Aug 1, 2015Hong Kong Baptist University
NCT02238587N/AJun 1, 2014Chang Bing Show Chwan Memorial Hospital
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Dalian Medical UniversityAcademic/Hospital2122016
Zhejiang UniversityAcademic/Hospital2222020
Capital Medical UniversityAcademic/Hospital1112018
Chang Bing Show Chwan Memorial HospitalAcademic/Hospital1112014
Hong Kong Baptist UniversityAcademic/Hospital1112015
The First Affiliated Hospital of Dalian Medical UniversityAcademic/Hospital1112016
6 organizations
Page 1 / 1